Additive effects of brimonidine tartrate 0.1%/brinzolamide 1% fixed-dose combination in prostaglandin analog-treated Japanese glaucoma patients

Purpose A brimonidine tartrate 0.1%/brinzolamide 1% fixed-dose combination (BBFC) was recently approved for glaucoma and ocular hypertension treatment in Japan. We investigated the efficacy and safety of BBFC used concomitantly with prostaglandin analogs (PG) or a PG/beta-blocker fixed-dose combinat...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Japanese journal of ophthalmology 2023-11, Vol.67 (6), p.668-677
Hauptverfasser:	Sakata, Rei, Mizoue, Shiro, Yoshikawa, Keiji, Adachi, Misato, Ohkubo, Shinji, Hamada, Naoki, Naito, Tomoko, Muramatsu, Tomoyuki, Hara, Takeshi, Asato, Ryo, Aihara, Makoto
Format:	Artikel
Sprache:	eng
Schlagworte:	Acuity Clinical Investigation Complications Glaucoma Hypertension Intraocular pressure Medicine Medicine & Public Health Ophthalmology Safety Visual acuity
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!